Diabetic Gastropathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2012-04-20
Clinical Trial Update: Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy [Phase 2]
Phase 2 trial assessing Tegaserod at 2 mg tid and 6 mg tid in diabetic patients with diabetic gastropathy was terminated.